Interim Director, Public Health Analytics, BC Centre for Disease Control
Senior Scientist, Hepatitis, BC Centre for Disease Control
Clinical Associate Professor, School of Population and Public Health, University of British Columbia
- Hepatitis B and C
- Syndemics of substance use, mental illness and blood-borne and sexually transmitted infections (STBBIs)
- Intervention effectiveness
- Health disparities
At BCCDC, Dr. Janjua provides leadership on surveillance, research and policy advice and programing related to hepatitis B and C in British Columbia. His research interests include hepatitis B and C epidemiology, syndemics of substance use, mental illness and blood-borne and sexually transmitted infections, intervention effectiveness, disparities in treatment access and disease outcomes, and strategies to enhance access to care. Most of his current work is based on the BC Hepatitis Testers Cohort. His global health research includes unsafe medical injections and transmission of bloodborne pathogens, socio-economic disparities in health, and scale up of hepatitis testing and treatment in South Asia developing countries. He has been involved in initiatives to design and scale up testing, linkage with care and treatment for HCV in various settings. He is also member of various national networks including Canadian Hepatitis C Network (CanHepC) and the CIHR Canadian HIV Trials Network (CTN).